Randomized controlled trial of sustained release tacrolimus vs twice daily tacrolimus in adult living donor liver transplantation

Efficacy and Safety Evaluation After Conversion From Twice-Daily to Once-Daily Tacrolimus in Stable Liver Transplant Recipients: A Phase 4, Open-Label, Single-Center Study

(2021) Woo-Hyoung Kang et al.   TRANSPLANTATION PROCEEDINGS

Randomized trial of steroid free immunosuppression with basiliximab induction in adult live donor liver transplantation (LDLT)

(2020) Manikandan Kathirvel et al.   HPB

Renal Function inDe NovoLiver Transplant Recipients Receiving Different Prolonged-Release Tacrolimus Regimens-The DIAMOND Study

(2015) P. TruneČka et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Conversion From Prograf to Advagraf in Stable Kidney Transplant Recipients: Better Renal Function After 3-Year Follow-up

(2014) G. Spagnoletti et al.   TRANSPLANTATION PROCEEDINGS

Effects of Converting Tacrolimus Formulation from Twice-Daily to Once-Daily in Liver Transplantation Recipients

(2014) Ashok Thorat et al.   Biomed Research International

Once-Daily Prolonged-Release Tacrolimus (ADVAGRAF) Versus Twice-Daily Tacrolimus (PROGRAF) in Liver Transplantation

(2010) P. Trunečka et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Evolution of Causes and Risk Factors for Mortality Post-Liver Transplant: Results of the NIDDK Long-Term Follow-Up Study

(2010) K. D. S. Watt et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Performance of the Cockcroft-Gault, MDRD, and New CKD-EPI Formulas in Relation to GFR, Age, and Body Size

(2010) W. M. Michels et al.   Clinical Journal of the American Society of Nephrology